Steroid Tapering in Pulmonary Sarcoidosis

Introduction to Tapering

The European Respiratory Society recommends reducing the prednisone dose gradually to the lowest dose that maintains symptom control and disease stability, with the goal of tapering over a total duration of 6-18 months from initiation 1

Before initiating the taper, evaluate clinical response, pulmonary function testing, and imaging at the 3-month mark, as recommended by the European Respiratory Society 1
Monitor patients every 3-6 months during the taper with clinical assessment, pulmonary function tests, and imaging, according to the European Respiratory Society guidelines 1
The European Respiratory Society suggests assessing symptom status, pulmonary function tests, and chest imaging for new or worsening infiltrates at each visit 1

For patients with improved disease, the European Respiratory Society recommends beginning dose reduction to find the lowest effective dose that provides satisfactory symptom relief and disease control 1
For patients with stable disease, reduce the steroid dose to the lowest dose that maintains disease control, avoiding complete withdrawal at this early stage, as recommended by the European Respiratory Society 1
If disease has worsened, do not taper steroids; instead, add adjunctive therapy with methotrexate or consider alternative diagnoses, according to the European Respiratory Society guidelines 1

Consider adding methotrexate (10-15 mg weekly) if steroid toxicity develops, unable to taper below 10 mg/day prednisone, high risk for steroid toxicity exists, or long-duration therapy is anticipated, as recommended by the European Respiratory Society and other guidelines 1, 2

If relapse occurs during or after tapering, restart prednisone at the last effective dose and add methotrexate as a steroid-sparing agent, according to the European Respiratory Society guidelines 1, 2

Avoid prolonged prednisone monotherapy at any dose, as even low doses (≥10 mg/day) cause significant toxicity, including weight gain, metabolic complications, and reduced quality of life, as noted by the European Respiratory Society 7
Patients requiring prednisone ≥10 mg/day beyond 6 months should receive methotrexate, according to guidelines 2
Provide calcium, vitamin D supplementation, and PPI for GI prophylaxis during prolonged steroid use, as recommended by guidelines 4, 5, 6